ESR1 and bone metastasis: Brain metastasis is associated with estrogen receptor (ER) negativity, HER-2/EGRF overexpression, and basal subtype [5–7], whereas bone metastasis is associated with ER positivity, and ER positivity/progesterone receptor (PR) negativity [4,9,10].